• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPHER METHKE GMBH & CO. KG PROGAV 2.0 SYS W/SA25 A.SPRUNG RESERVOIR; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPHER METHKE GMBH & CO. KG PROGAV 2.0 SYS W/SA25 A.SPRUNG RESERVOIR; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FX428T
Device Problem Restricted Flow rate (1248)
Patient Problem Failure of Implant (1924)
Event Date 01/15/2019
Event Type  malfunction  
Manufacturer Narrative
(b)(4).When additional information is received a follow up report will be submitted.
 
Event Description
It was reported by the healthcare professional "4m 18d po underdrain of valve." additional information has been requested however, not yet received.If additional information is received a follow up report will be submitted.
 
Manufacturer Narrative
Investigation: visual inspection: scratches on the outer housing of the valves were observed through the visual inspection.No significant deformations or damage were detected.Permeability test: a permeability test has shown that both valves are permeable.Adjustment test: the progav 2.0 valve was tested and is adjustable to all specified pressures.Braking force and brake function test: the brake functionality test has shown that the brake function is fully operational and the braking force is within the given tolerances.Computer controlled test: to test the opening pressure, we use a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.Both valves are operating within acceptable tolerances.Results: finally, we have dismantled the valves.There were no visible deposits inside the valves.Based on our investigation, we are unable to substantiate the claim of underdrainage.The valves operate within the specified tolerances.Despite no visible deposits being observed, it is possible that even a small amount of non-visible blood or protein can lead to a temporary blockage and could be responsible for the suspected malfunction in the past.As described in our literature, the problem described is one of the known, inevitable risks of hc-therapy by shunt implants.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGAV 2.0 SYS W/SA25 A.SPRUNG RESERVOIR
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPHER METHKE GMBH & CO. KG
2 ulanenweg
potsdam d, 14469
GM  14469
MDR Report Key8310174
MDR Text Key135158393
Report Number3004721439-2019-00024
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K161853
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 03/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/06/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/09/2023
Device Model NumberFX428T
Device Catalogue NumberFX428T
Device Lot Number20038541
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/18/2019
Distributor Facility Aware Date02/01/2019
Device Age6 MO
Date Manufacturer Received02/01/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-